货号:A166750 同义名:
米托蒽醌二盐酸盐
/ Mitozantrone dihydrochloride;NSC 301739 dihydrochloride
Mitoxantrone dihydrochloride是一种抗癌药物,通过抑制拓扑异构酶 II 和蛋白激酶 C(PKC),IC50 为 8.5 μM,具有抗肿瘤活性,也对正痘病毒具有抑制作用。
规格 | 价格 | 库存 | 数量 |
---|
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | Topo I ↓ ↑ | Topo II ↓ ↑ | Topo IV ↓ ↑ | Topoisomerase ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ellagic acid | ✔ | 98% | |||||||||||||||||
β-Lapachone | ✔ | 99%+ | |||||||||||||||||
(s)-10-hydroxycamptothecin | ✔ | 98+% | |||||||||||||||||
Camptothecin |
++
Topo I, IC50: 0.68 μM | 98% | |||||||||||||||||
Betulinic acid |
++
Eukaryotic topoisomerase I, IC50: 5 μM | 98% | |||||||||||||||||
Topotecan |
++++
Topo I (MCF-7 Luc cells), IC50: 13 nM Topo I (DU-145 Luc cells), IC50: 2 nM | 98% | |||||||||||||||||
Irinotecan HCl Trihydrate | ✔ | 98% | |||||||||||||||||
SN-38 | ✔ | 98% | |||||||||||||||||
Levofloxacin hydrate | ✔ | 98% | |||||||||||||||||
Dexrazoxane | ✔ | 99%+ | |||||||||||||||||
Ofloxacin | ✔ | 98+% | |||||||||||||||||
Enoxacin | ✔ | 99%+ | |||||||||||||||||
Flumequine |
+
Topo II, IC50: 15 μM | 98% | |||||||||||||||||
Levofloxacin | ✔ | 97% | |||||||||||||||||
Etoposide | ✔ | 98% | |||||||||||||||||
Pefloxacin mesylate dihydrate | ✔ | 99+% | |||||||||||||||||
Marbofloxacin | ✔ | 98+% | |||||||||||||||||
Voreloxin HCl | ✔ | 98% | |||||||||||||||||
Mitoxantrone 2HCl | ✔ | PKC | 98% | ||||||||||||||||
Nalidixic acid | ✔ | 98% | |||||||||||||||||
Doxorubicin | ✔ | 97% | |||||||||||||||||
Novobiocin sodium | ✔ | 95% | |||||||||||||||||
Amonafide | ✔ | 99%+ | |||||||||||||||||
Pirarubicin | ✔ | 98%+ | |||||||||||||||||
Idarubicin HCl |
+++
Topo II (MCF-7 cells), IC50: 3.3 ng/mL | 99%+ | |||||||||||||||||
Genistein | ✔ | EGFR | 98% | ||||||||||||||||
Teniposide | ✔ | 98% | |||||||||||||||||
Moxifloxacin | ✔ | 98% | |||||||||||||||||
Ciprofloxacin | ✔ | 98% | |||||||||||||||||
Clinafloxacin | ✔ | 99% | |||||||||||||||||
Gatifloxacin | ✔ | 98% | |||||||||||||||||
Daunorubicin HCl |
+++
DNA synthesis, Ki: 20 nM | 98% | |||||||||||||||||
Epirubicin HCl | ✔ | 99%+ | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
靶点 |
|
描述 | Mitoxantrone dihydrochloride is a potent topoisomerase II inhibitor. It is also showed inhibitory effect on protein kinase C (PKC) activity with IC50=8.5μM. Mitoxantrone inhibited PKC in a competitive manner with respect to histone H1 (Ki=6.3μM) and in a non-competitive manner with respect to phophatidylserine and ATP[3]. Mitoxantrone dihydrochloride (0.5 μg/mL, 48 h) induces a decrease in B-CLL cells. Mitoxantrone dihydrochloride induces DNA fragmentation and the proteolytic cleavage of poly(ADP-ribose) polymerase (PARP), demonstrating that the cytotoxic effect of Mitoxantrone dihydrochloride is due to induction of apoptosis[4]. Mitoxantrone dihydrochloride (IP, 0-3.2 mg/kg/day) produces a statistically significant number of 60-day survivors at 1.6 mg/kg in mice with IP implanted L1210 leukemia. Mitoxantrone dihydrochloride (IV, 0-3.2 mg/kg/day) shows effective antitumor activities and produces a 60% ILS (increase in lifespan) at 3.2 mg/kg in SC implanted Lewis lung carcinoma[5]. |
细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 |
A2780-cell | Growth inhibition assay | Concentration required to inhibit A2780-cell growth by 50%, IC50=0.55 nM | 9703471 | ||
A549 cells | Function assay | Activity against A549 cancer cell line, IC50=3.1 nM | 8960558 | ||
CCRF-CEM cells | Cytotoxicity assay | 48 h | Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 48 hrs by celltiter-blue assay, IC50=0.036 μM | 22582991 | |
CH1 cell | Cytotoxicity assay | Cytotoxic potency required to inhibit CH1 cell growth by 50%, IC50=2.65 nM | 9371240 | ||
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00004001 | Prostate Cancer | Phase 3 | Completed | - | United States, Arizona ... 展开 >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Health Plaza Saint Cloud, Minnesota, United States, 56303 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68106 United States, North Dakota Medcenter One Health System Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health System Grand Forks, North Dakota, United States, 58201 United States, Pennsylvania CCOP - Geisinger Clinic and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57104 收起 << |
NCT00002498 | Breast Cancer | Phase 2 | Unknown | - | Netherlands ... 展开 >> Leiden University Medical Center Leiden, Netherlands, 2300 ZA St. Radboud University Hospital Nijmegen, Netherlands, 6500 HB 收起 << |
NCT00219908 | Relapsing-Remitting Multiple S... 展开 >>clerosis 收起 << | Phase 2 | Terminated | - | France ... 展开 >> Hôpital Cote de Nacre Caen, France, 14033 Hôpital Gabriel Montpied Clermont-Ferrand, France, 63003 CHU Henri Mondor Creteil, France, 94000 Hôpital Général Dijon, France, 21033 CHU Limoges Limoges, France, 87042 Institut Catholique de Lille Lomme, France, 59462 Pierre Weitheimer Hospital Lyon, France, 69394 Chu Timone Marseille, France, 13385 Centre Guy de Chauliac Montpellier, France, 34295 CHU Hôpital Central Nancy, France, 54035 CHU Nice, France, 06000 CHU Pitié-Salpétrière Paris, France, 75013 Hôpital Saint-Anne Paris, France, 75014 Centre Fondation Rotschild Paris, France, 75019 Tenon Hospital Paris, France, 759170 CHU Strasbourg Strasbourg, France, 67000 CHU Purpan Toulouse, France, 31059 Italy Psichiatriche dell'Università di Bari, Policlinico Bari, Italy, 70122 Dipartimento di Scienze Neurologiche e Psichiatriche Firenze, Italy, 50134 Hospedal Civile Gallarate, Italy, 21013 Neuroriabilitazione dell'Università Genova, Italy, 16132 Fondazionz SAN Raffaele del monte tabor Milano, Italy, 20132 Clinica Neurologica Università di Torino Torino, Italy, 10126 收起 << |
计算器 | ||||
存储液制备 | ![]() | 1mg | 5mg | 10mg |
1 mM 5 mM 10 mM | 1.93mL 0.39mL 0.19mL | 9.66mL 1.93mL 0.97mL | 19.33mL 3.87mL 1.93mL |
CAS号 | 70476-82-3 |
分子式 | C22H30Cl2N4O6 |
分子量 | 517.4 |
别名 | 米托蒽醌二盐酸盐 ;Mitozantrone dihydrochloride;NSC 301739 dihydrochloride;NSC 301739;NCI 301739;Mitoxantrone (hydrochloride);Mitozantrone 2HCl;NSC-301739 2HCl;Mitoxantrone 2HCl |
运输 | 蓝冰 |
存储条件 | In solvent -20°C:3-6个月-80°C:12个月 Pure form Keep in dark place,Inert atmosphere,Room temperature |
溶解方案 | DMSO: 30 mg/mL(57.98 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 100 mg/mL(193.27 mM),配合低频超声助溶 |
动物实验配方 | PO 0.5% CMC-Na 30 mg/mL suspension |
Tags: Mitoxantrone dihydrochloride | Mitozantrone dihydrochloride;NSC 301739 dihydrochloride;NSC 301739;NCI 301739;Mitoxantrone (hydrochloride);Mitozantrone 2HCl;NSC-301739 2HCl;Mitoxantrone 2HCl | 米托蒽醌二盐酸盐 | Topoisomerase | AmBeed-信号通路专用抑制剂 | Mitoxantrone 2HCl 纯度/质量文件 | Mitoxantrone 2HCl 亚型比较 | Mitoxantrone 2HCl 生物活性 | Mitoxantrone 2HCl 细胞研究 | Mitoxantrone 2HCl 临床数据 | Mitoxantrone 2HCl 参考文献 | Mitoxantrone 2HCl 实验方案 | Mitoxantrone 2HCl 技术信息
请填写此表格索取QC报告。我们很快就会发送到您的邮箱。您的信息在我们这里是安全的。*是必填项.
靶点 | 数值 |
Topo II |
需要的总药量: mg
您需要配制的工作液浓度为:mg/mL
细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 |
A2780-cell | Growth inhibition assay | Concentration required to inhibit A2780-cell growth by 50%, IC50=0.55 nM | 9703471 | ||
A549 cells | Function assay | Activity against A549 cancer cell line, IC50=3.1 nM | 8960558 | ||
CCRF-CEM cells | Cytotoxicity assay | 48 h | Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 48 hrs by celltiter-blue assay, IC50=0.036 μM | 22582991 | |
CH1 cell | Cytotoxicity assay | Cytotoxic potency required to inhibit CH1 cell growth by 50%, IC50=2.65 nM | 9371240 | ||
FM3 cells | Proliferation assay | 72 h | Antiproliferative activity against human FM3 cells after 72 hrs by MTT assay, IC50=0.013 μM | 25998504 | |
G-361 cell | Growth inhibition assay | Cytotoxic potency required to inhibit G-361 cell growth by 50%, IC50=0.65 nM | 9371240 | ||
HCT116 cells | Cytotoxicity assay | Cytotoxicity against human HCT116 cells by MTT assay, IC50=3.96 μM | 20951582 | ||
HEK293 cells | Cytotoxicity assay | 72 h | Cytotoxicity against HEK293 cells after 72 hrs by MTT assay, IC50=0.01 μM | 24611893 | |
HeLa cells | Proliferation assay | 72 h | Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay, IC50=0.044 μM | 25998504 | |
HepG2 cells | Proliferation assay | 48 h | Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay, IC50=11.05 μM | 24794747 | |
HL60 cells | Cytotoxicity assay | 48 h | Cytotoxicity against human HL60 cells after 48 hrs by MTT assay, GI50=0.33 μM | 17962028 | |
HT1080 cell | Growth inhibition assay | Inhibitory activity against human tumor cell line HT1080, IC50=0.066 μM | 7853345 | ||
HT-29 cell | Cytotoxicity assay | 144 h | Cytotoxic potency required to inhibit HT-29 cell growth by 50% after cell drug contact for 144 hrs, IC5=0.01 μM | 9371240 | |
human Daudi cells | Proliferation assay | 72 h | Antiproliferative activity against human Daudi cells after 72 hrs by MTT assay, IC50=5 nM | 25998504 | |
human HCT116 cells | Cytotoxicity assay | 72 h | Cytotoxicity against human HCT116 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay, IC50=0.022 μM | 21444205 | |
human HCT116 cells | Proliferation assay | 72 h | Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay, IC50=0.025 μM | 25998504 | |
human HL60 cells | Proliferation assay | 72 h | Antiproliferative activity against human HL60 cells after 72 hrs by SRB assay, IC50=2.5 nM | 22944121 | |
human K562 cells | Cytotoxicity assay | 5 days | Cytotoxicity against human K562 cells after 5 days by XTT assay, IC50=2.6 nM | 18076140 | |
human MES-SA cells | Proliferation assay | 72 h | Antiproliferative activity against human MES-SA cells after 72 hrs by MTT assay, IC50=6 nM | 25998504 | |
human small-cell lung cancer | Cytotoxicity assay | Cytotoxicity against human small-cell lung cancer (SCLC), IC50=0.02 μM | 8258835 | ||
K562 cells | Growth inhibition assay | 72 h | Growth inhibition of human K562 cells after 72 hrs by MTS method, IC50=0.42 μM | 18258442 | |
KB/HeLa cells | Proliferation assay | 48 h | Antiproliferative activity against human KB/HeLa cells after 48 hrs, EC50=0.36 μM | 23395656 | |
L1210 cell | Cytotoxicity assay | 48 h | Cytotoxic potency required to inhibit L1210 cell growth by 50% after cell drug contact for 48 hrs, IC50=4e-05 μM | 9371240 | |
LoVo cells | Cytotoxicity assay | 144 h | Cytotoxicity against human LoVo cancer cell line was determined after 144 hr, IC50=3.3 nM | 15456268 | |
MCF-7 cells | Growth inhibition assay | Inhibitory activity against human tumor cell line MCF-7 breast adenocarcinoma, IC50=0.02 μM | 7853345 | ||
MDA435/LCC6 cells | Proliferation assay | Antiproliferative activity against MDA435/LCC6 cells by ELISA, IC50=0.35 nM | 17154505 | ||
MDA-MB-231 cells | Proliferation assay | 72 h | Antiproliferative activity against human MDA-MB-231 cells by WST-1 method after 72 hrs, IC50=0.96 μM | 17335189 | |
MES-SA cells | Proliferation assay | 72 h | Antiproliferative activity against MES-SA cells by MTT assay after 72 hrs, IC50=3 nM | 16824751 | |
MES-SA cells | Cytotoxicity assay | 72 h | Cytotoxicity against human MES-SA cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay, IC50=0.012 μM | 21444205 | |
MES-SA/Dx5 cells | Proliferation assay | 72 h | Antiproliferative activity against human MES-SA/Dx5 cells after 72 hrs by MTT assay, IC50=0.073 μM | 25998504 | |
MKN45 cells | Cytotoxicity assay | 144 h | Cytotoxicity against human MKN45 cancer cell line was determined after 144 hr, IC50=0.012 μM | 15456268 | |
MXF7 breast cell | Function assay | Antitumor activity against human mammary carcinoma sensitive MXF7 breast cell line, IC50=8.7 nM | 8960558 | ||
NCI60 cells | Function assay | 48 h | Antitumor activity against human NCI60 cells after 48 hrs by SRB assay, GI50=47.86 nM | 18715786 | |
NCI-H460 cells | Cytotoxicity assay | 48 h | Cytotoxicity against human NCI-H460 cells after 48 hrs by resazurin dye assay, EC50=0.03 μM | 23988351 | |
OVCAR-3 cell | Function assay | Antitumor activity against human ovarian OVCAR-3 cell lines, IC50=5.8 nM | 8960558 | ||
P388 cells | Proliferation assay | Antiproliferative activity against P388 cells by ELISA, IC50=4.3 nM | 17154505 | ||
PC3 cancer cell | Cytotoxicity assay | 144 h | Cytotoxicity against human PC3 cancer cell line was determined after 144 hr, IC50=7 nM | 15456268 | |
SF268 cells | Proliferation assay | 48 h | Antiproliferative activity against human SF268 cells after 48 hrs, EC50=0.32 μM | 23395656 | |
SF268 cells | Cytotoxicity assay | 48 h | Cytotoxicity against human SF268 cells after 48 hrs by SRB assay, GI50=0.97 μM | 17962028 | |
SKOV-3 cell | Cytotoxicity assay | Cytotoxic potency required to inhibit SKOV-3 cell growth 50%, IC50=5.3 nM | 9371240 | ||
U937 cells | Cytotoxicity assay | Cytotoxicity against human U937 cells by MTT assay, IC50=6.2 μM | 19615900 | ||
UACC375 cell | Function assay | Antitumor activity against human melanoma UACC375 cell line, IC50=0.048 μM | 8960558 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00004001 | Prostate Cancer | Phase 3 | Completed | - | United States, Arizona ... 展开 >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Health Plaza Saint Cloud, Minnesota, United States, 56303 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68106 United States, North Dakota Medcenter One Health System Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health System Grand Forks, North Dakota, United States, 58201 United States, Pennsylvania CCOP - Geisinger Clinic and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57104 收起 << |
NCT00002498 | Breast Cancer | Phase 2 | Unknown | - | Netherlands ... 展开 >> Leiden University Medical Center Leiden, Netherlands, 2300 ZA St. Radboud University Hospital Nijmegen, Netherlands, 6500 HB 收起 << |
NCT00219908 | Relapsing-Remitting Multiple S... 展开 >>clerosis 收起 << | Phase 2 | Terminated | - | France ... 展开 >> Hôpital Cote de Nacre Caen, France, 14033 Hôpital Gabriel Montpied Clermont-Ferrand, France, 63003 CHU Henri Mondor Creteil, France, 94000 Hôpital Général Dijon, France, 21033 CHU Limoges Limoges, France, 87042 Institut Catholique de Lille Lomme, France, 59462 Pierre Weitheimer Hospital Lyon, France, 69394 Chu Timone Marseille, France, 13385 Centre Guy de Chauliac Montpellier, France, 34295 CHU Hôpital Central Nancy, France, 54035 CHU Nice, France, 06000 CHU Pitié-Salpétrière Paris, France, 75013 Hôpital Saint-Anne Paris, France, 75014 Centre Fondation Rotschild Paris, France, 75019 Tenon Hospital Paris, France, 759170 CHU Strasbourg Strasbourg, France, 67000 CHU Purpan Toulouse, France, 31059 Italy Psichiatriche dell'Università di Bari, Policlinico Bari, Italy, 70122 Dipartimento di Scienze Neurologiche e Psichiatriche Firenze, Italy, 50134 Hospedal Civile Gallarate, Italy, 21013 Neuroriabilitazione dell'Università Genova, Italy, 16132 Fondazionz SAN Raffaele del monte tabor Milano, Italy, 20132 Clinica Neurologica Università di Torino Torino, Italy, 10126 收起 << |
NCT00262314 | - | Completed | - | United States, Kentucky ... 展开 >> Registrat Inc Lexington, Kentucky, United States, 40504-3276 收起 << | |
NCT02687386 | Solid Tumours ... 展开 >> CNS Tumours 收起 << | Phase 1 | Recruiting | April 2021 | Australia, New South Wales ... 展开 >> Sydney Children's Hospital Recruiting Randwick, New South Wales, Australia, 2031 Contact: David Ziegler, MBBS +61293821730 Contact: Dominique Hess, PhD +61293823122 Dominique.Hess@health.nsw.gov.au Principal Investigator: David Ziegler, MBBS Sub-Investigator: Toby Trahair, MBBS The Children's Hospital at Westmead Recruiting Westmead, New South Wales, Australia Principal Investigator: Geoff McCowage 收起 << |
NCT00015951 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342-1601 United States, Maryland Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 收起 << |
NCT00185445 | Non Hodgkin Lymphoma | Phase 2 | Completed | - | Italy ... 展开 >> Bologna, BO, Italy, 40138 Cesena, FC, Italy, 47023 Forlì, FC, Italy, 47100 Genova, GE, Italy, 16132 Roma, RM, Italy, 00144 Roma, RM, Italy, 00168 Rimini, RN, Italy, 47900 Cagliari, Italy, 09121 Firenze, Italy, 50139 Napoli, Italy, 80131 Ravenna, Italy, 48100 Roma, Italy, 00161 Siena, Italy, 53100 Udine, Italy, 33100 收起 << |
NCT00770848 | Cancer Castra... 展开 >>te-Resistant Prostate Cancer Mestastatic Prostate Cancer Prostate Cancer 收起 << | Phase 1 Phase 2 | Completed | - | - |
NCT00169208 | Follicular Lymphoma | Phase 2 | Completed | - | France ... 展开 >> Service de médecine D - Maladies du Sang CHU Angers Angers, France, 49033 Service d'Hématologie Hôpital Jean Minjoz Besançon, France, 25030 Hôpital Henri Mondor Créteil, France, 94010 Hôpital A. Michallon BP 217X Grenoble, France, 38043 Service Oncologie - Centre Victor Hugo Le Mans, France, 72015 Service d'hématologie clinique - Centre Hospitalier du Dr Schaffner Lens, France, 62307 Hôpital Claude Huriez - Sce des Maladies du Sang - Place Verdun Lille, France, 59037 Centre Hospitalier Lyon-sud Lyon, France, 69310 Centre régional de lutte contre le cancer Léon Bérard Lyon, France, 69373 Service d'hématologie Institut Paoli Calmette Marseille, France, 13273 Service d'hématologie - Hôpital Necker Paris, France, 75015 Service d'Hématologie Hôpital St Louis Paris, France, 75475 Service d'hématologie clinique - Hôpital de Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76038 Service Oncologie CHU Bretonneau Tours, France, 37044 Service d'hématologie Institut Gustave Roussy Villejuif, France, 94805 收起 << |
NCT01126814 | Leukemia | Phase 1 Phase 2 | Completed | - | Canada, Ontario ... 展开 >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT00262314 | - | Completed | - | - | |
NCT02728050 | Acute Biphenotypic Leukemia ... 展开 >> Acute Myeloid Leukemia de Novo Myelodysplastic Syndrome High Risk Myelodysplastic Syndrome Myelodysplastic Syndrome Myeloproliferative Neoplasm 收起 << | Phase 1 Phase 2 | Recruiting | - | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Anna Halpern 206-314-5944 halpern2@uw.edu Principal Investigator: Anna Halpern 收起 << |
NCT00510887 | - | Terminated(Low accrual.) | - | - | |
NCT00577993 | Lymphoma | Phase 3 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00003003 | Leukemia | Phase 1 | Completed | - | United States, New Hampshire ... 展开 >> Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756 收起 << |
NCT00004071 | Prostate Cancer | Phase 2 Phase 3 | Completed | - | United States, Florida ... 展开 >> Comprehensive Cancer Care Specialists of Boca Raton Boca Raton, Florida, United States, 33428 Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, New York St. Vincents Comprehensive Cancer Center New York, New York, United States, 10011 收起 << |
NCT01027923 | Leukemia, Myeloid, Acute | Phase 1 | Terminated(Withdrawal of suppo... 展开 >>rt from sponsor) 收起 << | - | United States, Missouri ... 展开 >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 收起 << |
NCT00510887 | Lymphoma, Follicular | Phase 2 | Terminated(Low accrual.) | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT01204710 | Prostate Cancer | Phase 2 | Completed | - | - |
NCT01204710 | - | Completed | - | - | |
NCT00774046 | Myelodysplastic Syndrome ... 展开 >> Acute Myeloid Leukemia 收起 << | Phase 2 | Completed | - | United States, Illinois ... 展开 >> The University of Chicago Chicago, Illinois, United States, 60637 收起 << |
NCT00182741 | Prostate Cancer | Phase 2 | Completed | - | United States, Oregon ... 展开 >> Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 收起 << |
NCT03735446 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndromes 收起 << | Phase 1 | Not yet recruiting | June 1, 2021 | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Eric s Winer, MD 617-632-3000 EricS_Winer@DFCI.HARVARD.EDU Principal Investigator: Eric S. Winer, MD 收起 << |
NCT00774046 | - | Completed | - | - | |
NCT00017563 | Prostate Cancer | Phase 2 | Completed | - | United States, Oregon ... 展开 >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Portland VA Medical Center Portland, Oregon, United States, 97239 收起 << |
NCT00024492 | Tumors | Phase 1 | Completed | - | United States, California ... 展开 >> City of Hope National Medical Center Duarte, California, United States, 91010 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Ohio The Ohio State University Columbus, Ohio, United States, 43210 收起 << |
NCT01065727 | Multiple Sclerosis | Not Applicable | Recruiting | February 2019 | France ... 展开 >> CHU Cavale Blanche Recruiting Brest, France, 29609 Contact: Rouhart Francois, MD francois.rouhart@chu-brest.fr CHU Rennes Recruiting Rennes, France, 35033 Contact: Emmauelle Le Page, MD emmanuelle.lepage@chu-rennes.fr 收起 << |
NCT00017563 | - | Completed | - | - | |
NCT01133158 | Non-Hodgkin's Lymphoma | Phase 2 | Completed | - | Spain ... 展开 >> Complejo Hospitalario Universitario de Santiago Santiago, A Coruña, Spain, 15706 Hospital Txagorritxu Vitoria, Alava, Spain, 01009 Hospital San Juan de Alicante San Juan de Alicante, Alicante, Spain, 03550 Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital de Galdakao Galdakao, Bilbao, Spain, 48960 Hospital Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital de Jerez Jerez de la Frontera, Cádiz, Spain, 11407 Hospital Fundación de Alcorcón Alcorcón, Madrid, Spain, 289222 Hospital de Getafe Getafe, Madrid, Spain, 28901 Hospital Severo Ochoa Leganés, Madrid, Spain, 28911 Hospital Puerta de Hierro Majadahonda, Madrid, Spain, 28222 Hospital Son Llàtzer Palma de Mallorca, Mallorca, Spain, 07010 Hospital Son Espases Palma de Mallorca, Mallorca, Spain, 07014 Hospital Universitario Virgen de Arrixaca El Palmar, Murcia, Spain, 30120 Clínica Universitaria de Navarra Pamplona, Navarra, Spain, 31008 Hospital Universitario de Canarias La Laguna, Tenerife, Spain, 38320 Complejo Hospitalario Universitario A Coruña A Coruña, Spain, 15006 Hospital del Mar Barcelona, Spain, 08003 Hospital Vall d´Hebron Barcelona, Spain, 08035 Hospital Clinic i Provincial Barcelona, Spain, 08036 Hospital de Basurto Bilbao, Spain, 48013 Hospital San Pedro Alcántara Cáceres, Spain, 10002 Hospital Puerta del Mar Cádiz, Spain, 11009 Hospital de Jaén Jaén, Spain, 23007 Hospital Gregorio Marañón Madrid, Spain, 28009 Hospital Ramón y Cajal Madrid, Spain, 28034 Hospital 12 de Octubre Madrid, Spain, 28041 Hospital La Paz Madrid, Spain, 28046 Hospital Morales Meseguer Murcia, Spain, 30008 Complejo Hospitalario Carlos Haya Málaga, Spain, 29010 Hospital de Salamanca Salamanca, Spain, 37007 Hospital General de Segovia Segovia, Spain, 42002 Hospital Virgen del Rocío Sevilla, Spain, 41013 Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 Hospital General de Valencia Valencia, Spain, 46014 Hospital Arnau de Vilanova Valencia, Spain, 46015 Hospital Universitario Dr. Peset Valencia, Spain, 46017 Hospital Río Hortega Valladolid, Spain, 47012 Hospital Virgen de la Concha Zamora, Spain, 49022 Hospital Clínico de Zaragoza Zaragoza, Spain, 50009 Hospital Miguel Servet Zaragoza, Spain, 50009 收起 << |
NCT01133158 | - | Completed | - | - | |
NCT00385827 | Cancer, Prostate | Phase 2 | Terminated(Prematurely stopped... 展开 >> after Independent Data Monitoring Committee (IDMC) evaluation for lack of efficacy.) 收起 << | - | - |
NCT00385827 | - | Terminated(Prematurely stopped... 展开 >> after Independent Data Monitoring Committee (IDMC) evaluation for lack of efficacy.) 收起 << | - | - | |
NCT00327340 | Prostate Cancer | Phase 2 | Completed | - | Canada, Alberta ... 展开 >> Tom Baker Cancer Centre Calgary, Alberta, Canada Cross Cancer Institute Edmonton, Alberta, Canada Canada, British Columbia BC Cancer Agency Vancouver, British Columbia, Canada Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada Canada, Nova Scotia QEII Health Sciences Halifax, Nova Scotia, Canada Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada London Regional Cancer Program London, Ontario, Canada Toronto Sunnybrook Toronto, Ontario, Canada Canada, Quebec Jewish General Hospital Montreal, Quebec, Canada University of Montreal Montreal, Quebec, Canada 收起 << |
NCT01127009 | Adult Acute Megakaryoblastic L... 展开 >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia 收起 << | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 << |
NCT00119730 | Mantle Cell Lymphoma | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT00003183 | Prostate Cancer | Phase 1 Phase 2 | Unknown | - | United States, Kansas ... 展开 >> Bethany Medical Center Kansas City, Kansas, United States, 66102 Heartland Cancer Research and Treatment Center Kansas City, Kansas, United States, 66106 收起 << |
NCT00327340 | - | Completed | - | - | |
NCT00002544 | Breast Cancer | Phase 3 | Completed | - | Germany ... 展开 >> Diakonissen-Krankenhaus Stuttgart Stuttgart, Germany, D-70176 收起 << |
NCT00058084 | Adenocarcinoma of the Prostate... 展开 >> Recurrent Prostate Cancer Stage IV Prostate Cancer 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94143-0875 收起 << |
NCT03531918 | Acute Myeloid Leukemia ... 展开 >> High-Grade Myeloid Neoplasm 收起 << | Phase 1 Phase 2 | Recruiting | July 1, 2025 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Roland Walters 206-667-3599 rwalter@fredhutch.org Principal Investigator: Roland Walters 收起 << |
NCT01523860 | Follicular Lymphoma | Phase 2 | Completed | - | Italy ... 展开 >> Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) Meldola, Forlì-Cesena, Italy, 47014 Ematologia e Trapianto Ospedale Card.Panico Tricase, Lecce, Italy Ematologia, A.O. San Gerardo Monza, Milano, Italy, 20052 Oncologia Medica ed Ematologia, Istituto Clinica Humanitas Rozzano, Milano, Italy, 20089 Divisione di Oncologia Medica A, Centro di Riferimento Oncologico Aviano, Pordenone, Italy, 33081 UO Oncologia ed Onco-Ematologia, Ospedale di Rimini Rimini, Rn, Italy Divisione di Ematologia Ospedale SS. Antonio e Biagio Alessandria, Italy, 15100 SOS Ematologia Ospedale C. Massaia Asti, Italy, 14100 Ematologia con Trapianto, Università di Bari Bari, Italy, 70124 Medicina Interna, Ospedale degli Infermi Biella, Italy, 13800 Istituto di Ematologia ed Oncologia Medica A. Seragnoli Policlinico S. Orsola Bologna, Italy, 40138 Divisione di Ematologia e TMO, Ospedale di Bolzano Bolzano, Italy, 39100 S.C. di Ematologia, Spedali Civili Brescia, Italy, 25123 Divisione di Ematologia, Ospedale Businco Cagliari, Italy, 09121 Divisione di Ematologia, Ospedale di Catania Catania, Italy Azienda Ospedaliera Santa Croce e Carle Cuneo, Italy, 12100 Clinica Ematologica Policlinico Carreggi Firenze, Italy, 50134 Divisione di Ematologia, Policlinico Careggi Firenze, Italy Ematologia I, A.O.U. San Martino Genova, Italy, 16132 S.C. Medicina Trasfusionale ed Ematologia , P.O. Ivrea Ivrea, Italy, 10015 S.C. Ematologia, Azienda Ospedaliera Papardo Messina, Italy, 98158 Divisione di Ematologia, Ospedale Niguarda Milano, Italy, 20162 Ematologia e Trapianto IRCCS, Istituto Nazionale dei Tumori Milano, Italy Policlinico La Marcora Milano, Italy UO Ematologia, II Facoltà di Medicina e Chirurgia Università Federico II Napoli, Italy, 80131 SCDU Ematologia, AOU Maggiore della Carità Novara, Italy, 28100 UO Ematologia, Università - Policlinico San Matteo Pavia, Italy, 27100 Ematologia Ospedale Santa Maria delle Croci Ravenna, Italy, 48100 Div. Ematologia A.O. "Bianchi Melacrino Morelli" Reggio Calabria, Italy, 89100 Università Cattolica del Sacro Cuore Roma, Italy, 00168 Dipartimento di biotecnologie cellulari ed ematologia Ospedale Umberto I, Università La Sapienza Roma, Italy Ospedale Santa Maria di Terni Terni, Italy, 05100 Osp. San Giovanni Battista - Biologia Molecolare Torino, Italy, 10126 Osp. San Giovanni Battista - Ematologia 2 Torino, Italy, 10126 Ospedale S. Chiara Trento, Italy Ematologia Ospedale Santa Maria Di Ca' Foncello Treviso, Italy, 31100 Clinica di Ematologia, A.O.U. di Udine Udine, Italy, 33100 收起 << |
NCT00183989 | Mantle Cell Lymphoma | Phase 2 | Terminated(Insufficient accrua... 展开 >>l) 收起 << | - | United States, California ... 展开 >> Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 收起 << |
NCT01729845 | Previously Treated Myelodyspla... 展开 >>stic Syndrome Recurrent Adult Acute Myeloid Leukemia 收起 << | Phase 1 Phase 2 | Completed | - | United States, Washington ... 展开 >> Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States, 99336 EvergreenHealth Medical Center Kirkland, Washington, United States, 98033 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT02597153 | Relapsed Cutaneous T Cell Lymp... 展开 >>hom 收起 << | Phase 2 | Terminated(Just one subject en... 展开 >>rolled in this trial during one and a half years.) 收起 << | October 2020 | China ... 展开 >> Beijing Cancer Hospital Beijing, China 收起 << |
NCT01729845 | - | Completed | - | - | |
NCT00656084 | Relapsed or Refractory Mantle ... 展开 >>Cell Lymphoma (MCL) 收起 << | Phase 2 | Completed | - | - |
NCT00331344 | Adenocarcinoma of the Prostate... 展开 >> Recurrent Prostate Cancer Stage IV Prostate Cancer 收起 << | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94143-0875 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 收起 << |
NCT00331344 | - | Completed | - | - | |
NCT00004124 | Prostate Cancer | Phase 3 | Active, not recruiting | June 1, 2022 | - |
NCT00656084 | - | Completed | - | - | |
NCT00274963 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | Germany ... 展开 >> Humaine - Clinic Bad Saarow, Germany, 15526 Schwerpunktpraxis fuer Haematologie und Internistische Onkologie Berlin, Germany, D-10117 Internistische Gemeinschaftspraxis - Halle Halle, Germany, 06110 St. Marien Hospital Hamm, Germany, 59065 Praxis fuer Haematologie und Onkologie Koblenz, Germany, D-56068 Praxis Fuer Haematologie Internistische Onkologie Koeln, Germany, D-50677 Haematologische / Onkologische Schwerpunktpraxis Krefeld, Germany, 47798 Internistische Onkologische Praxis - Kronach Kronach, Germany, 96317 Internistische Praxis - Neuss Neuss, Germany, 41460 Internistische Gemeinschaftspraxis - Oldenburg Oldenburg, Germany, 26121 Haematologische Praxis Weiden, Germany, D-92637 Deutsche Klinik fuer Diagnostik Wiesbaden, Germany, D-65191 收起 << |
NCT00002003 | Lymphoma, Non-Hodgkin ... 展开 >> HIV Infections 收起 << | Phase 2 | Completed | - | United States, New Jersey ... 展开 >> UMDNJ - New Jersy Med School Newark, New Jersey, United States, 071032714 United States, New York New York Univ Med Ctr New York, New York, United States, 10016 Saint Luke's - Roosevelt Hosp Ctr New York, New York, United States, 10019 收起 << |
NCT00254410 | - | Completed | - | - | |
NCT00254410 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00795002 | Acute Myeloid Leukemia With Mu... 展开 >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00470197 | Adult Acute Megakaryoblastic L... 展开 >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Malignant Neoplasm Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 收起 << |
NCT00512252 | Leukemia, Myeloid, Acute | Phase 1 Phase 2 | Completed | - | United States, Missouri ... 展开 >> Washington University St. Louis, Missouri, United States, 63110 收起 << |
NCT00004124 | - | Active, not recruiting | - | - | |
NCT02921061 | Mixed Phenotype Acute Leukemia... 展开 >> Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Recurrent High Risk Myelodysplastic Syndrome Refractory Acute Myeloid Leukemia Refractory High Risk Myelodysplastic Syndrome Untreated Adult Acute Myeloid Leukemia 收起 << | Phase 1 Phase 2 | Recruiting | - | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Sarah A. Buckley 206-416-5066 sbuckley@fredhutch.org Principal Investigator: Sarah A. Buckley 收起 << |
NCT00795002 | - | Completed | - | - | |
NCT02070458 | Recurrent Adult Acute Myeloid ... 展开 >>Leukemia Refractory Acute Myeloid Leukemia 收起 << | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 收起 << |
NCT00016016 | Recurrent Adult Acute Lymphobl... 展开 >>astic Leukemia Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia 收起 << | Phase 1 Phase 2 | Completed | - | United States, Maryland ... 展开 >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 收起 << |
NCT00683475 | Prostate Cancer | Phase 2 | Completed | - | - |
NCT00512252 | - | Completed | - | - | |
NCT00683475 | - | Completed | - | - | |
NCT02937285 | Multiple Sclerosis | Phase 3 | Active, not recruiting | November 2020 | France ... 展开 >> CHU Rennes Rennes, France 收起 << |
NCT00410423 | Relapsed Acute Leukemia ... 展开 >> Refractory Acute Leukemia 收起 << | Phase 1 Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 收起 << |
NCT01349972 | Acute Myeloid Leukemia With Mu... 展开 >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Scottsdale-Phoenix Scottsdale, Arizona, United States, 85259 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 收起 << |
NCT00609739 | Leukemia | Phase 1 Phase 2 | Terminated(Low accrual) | - | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00609739 | - | Terminated(Low accrual) | - | - | |
NCT01349972 | - | Completed | - | - | |
NCT00417079 | - | Completed | - | - | |
NCT00417079 | Neoplasms Pro... 展开 >>static Neoplasms 收起 << | Phase 3 | Completed | - | - |
NCT00410423 | - | Completed | - | - | |
NCT00452387 | Metastatic Prostate Cancer | Phase 2 | Terminated(Early stopping rule... 展开 >>) 收起 << | - | United States, California ... 展开 >> Wilshire Oncology Medical Group, Inc. La Verne, California, United States, 91750 United States, Georgia Peachtree Hematology Oncology Consultants Atlanta, Georgia, United States, 30309 Central Georgia Cancer Care Macon, Georgia, United States, 31201 Northwest Georgia Oncology Centers Marietta, Georgia, United States, 30060 United States, Montana Hematology Oncology Centers of the Northern Rockies, PC Billings, Montana, United States, 59101 United States, Ohio Mid-Ohio Oncology/Hematology, Inc. Columbus, Ohio, United States, 43213 United States, Pennsylvania Lancaster Cancer Center Lancaster, Pennsylvania, United States, 17605 Pennsylvania Oncology Hematmology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 United States, Virginia Cancer Specialists of Tidewater Chesapeake, Virginia, United States, 23320 收起 << |
NCT02573363 | Acute Myeloid Leukemia | Phase 1 | Active, not recruiting | January 2020 | United States, Illinois ... 展开 >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 收起 << |
NCT03118466 | AML | Phase 2 | Recruiting | September 30, 2024 | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02062 Contact: Richard Stone, MD 617-632-2214 Richard_Stone@dfci.harvard.edu Principal Investigator: Richard Stone, MD Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Lourdes Mendez, MD 617-667-9920 Principal Investigator: Lourdes Mendez, MD Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Andrew Brunner, MD 617-724-1124 Andrew_Brunner@DFCI.HARVARD.EDU Principal Investigator: Andrew Brunner, MD 收起 << |
NCT01578343 | Mantle Cell Lymphoma | Phase 2 | Terminated(we collected data o... 展开 >>f a total of 19 patients for an interim analysis. but there are less than 7 responses out of the initial 19 patients.) 收起 << | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 收起 << |
NCT00208975 | - | Terminated(slow accrual) | - | - | |
NCT00452387 | - | Terminated(Early stopping rule... 展开 >>) 收起 << | - | - | |
NCT01222143 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Terminated | - | Canada, Ontario ... 展开 >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT01522443 | Prostate Cancer ... 展开 >> Castration Resistant Prostate Cancer Pain Prostatic Neoplasms 收起 << | Phase 3 | Terminated(Stopped after the o... 展开 >>utcome of cabozantinib Phase 3 CRPC study XL184-307.) 收起 << | - | - |
NCT00002259 | Sarcoma, Kaposi ... 展开 >> HIV Infections 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Saint Luke's - Roosevelt Hosp Ctr New York, New York, United States, 10019 收起 << |
NCT00208975 | Lymphoma | Phase 2 | Terminated(slow accrual) | - | United States, Georgia ... 展开 >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 收起 << |
NCT00146159 | Secondary Progressive Multiple... 展开 >> Sclerosis 收起 << | Phase 3 | Terminated | - | Germany ... 展开 >> Berg, Germany, D-82335 Berlin, Germany, D-13347 Düsseldorf, Germany, D-40225 Düsseldorf, Germany, D-40479 Gießen, Germany, D-35385 Marburg, Germany, D-35039 Wiesbaden, Germany, D-65191 收起 << |
NCT00407966 | Adult Acute Basophilic Leukemi... 展开 >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 收起 << |
NCT00407966 | - | Completed | - | - | |
NCT01768897 | Adult Acute Myeloid Leukemia W... 展开 >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia 收起 << | Phase 1 | Completed | - | United States, North Carolina ... 展开 >> Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 收起 << |
NCT01522443 | - | Terminated(Stopped after the o... 展开 >>utcome of cabozantinib Phase 3 CRPC study XL184-307.) 收起 << | - | - | |
NCT02856685 | Non-Hodgkin's Lymphoma | Phase 1 Phase 2 | Unknown | May 2018 | United States, Ohio ... 展开 >> Gabrail Cancer Center Research Recruiting Canton, Ohio, United States Contact: Nashat Y Gabrail, MD 收起 << |
NCT03504410 | Relapsed/Refractory Acute Myel... 展开 >>oid Leukemia 收起 << | Phase 3 | Recruiting | March 2023 | United States, North Carolina ... 展开 >> Wake Forest Baptist Health Recruiting Winston-Salem, North Carolina, United States, 27157 Principal Investigator: Bayard L Powell, MD United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Principal Investigator: Aziz Nazha, MD 收起 << |
NCT00546377 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 1 Phase 2 | Completed | - | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT01342887 | - | Terminated | - | - | |
NCT00546377 | - | Completed | - | - | |
NCT00304291 | Neuromyelitis Optica ... 展开 >> Myelitis, Transverse Demyelinating Autoimmune Diseases, CNS Autoimmune Diseases of the Nervous System 收起 << | Phase 4 | Completed | - | United States, New York ... 展开 >> Baird Multiple Sclerosis Center Buffalo, New York, United States, 14203 收起 << |
NCT02044796 | Acute Biphenotypic Leukemia ... 展开 >> de Novo Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia 收起 << | Phase 1 Phase 2 | Active, not recruiting | August 1, 2022 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00003858 | Prostate Cancer | Phase 2 | Withdrawn(The study was not ac... 展开 >>tivated.) 收起 << | - | - |
NCT01342887 | Adult Acute Megakaryoblastic L... 展开 >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia 收起 << | Phase 1 Phase 2 | Terminated | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT02597387 | Relapsed DLBCL and PT/NKCLs | Phase 2 | Recruiting | October 2018 | China ... 展开 >> Beijing Cancer Hospital Recruiting Beijing, China Contact: Mi Jiang, Ph.D 收起 << |
NCT02484391 | Granulocytic Sarcoma ... 展开 >> Recurrent Adult Acute Myeloid Leukemia 收起 << | Phase 2 | Recruiting | February 2022 | United States, North Carolina ... 展开 >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Scarlett Hutchens 336-713-6915 snhutche@wakehealth.edu Principal Investigator: Timothy S. Pardee 收起 << |
NCT02631252 | Leukemia, Acute Myelogenous | Phase 1 | Terminated(Inability to accrue... 展开 >>) 收起 << | - | United States, Pennsylvania ... 展开 >> University of Pittsburgh Cancer Institute - Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 收起 << |
NCT01260714 | Acute Myeloid Leukemia Arising... 展开 >> From Previous Myelodysplastic Syndrome Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With Minimal Differentiation Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Adult Erythroleukemia Adult Pure Erythroid Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia 收起 << | Phase 1 | Terminated(Inadequate accrual ... 展开 >>rate) 收起 << | - | Canada, Ontario ... 展开 >> Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT00447473 | Prostatic Neoplasms | Phase 2 | Terminated(PI decision) | - | United States, Texas ... 展开 >> Baylor College of Medicine - Methodist Hospital Houston, Texas, United States, 77030 收起 << |
NCT02686593 | Acute Myeloid Leukemia | Phase 2 | Completed | - | Hong Kong ... 展开 >> The University of Hong Kong Hong Kong, Hong Kong 收起 << |
NCT03258320 | Prostate Cancer Patients | Phase 1 | Recruiting | December 2020 | China, Shandong ... 展开 >> Qilu Hospital of Shandong University Recruiting Qingdao, Shandong, China, 266035 Contact: Jiannan Chen, Ph.D 86-0532-96599654 submarinesuny@yahoo.com China Zhongshan Hospital Recruiting Shanghai, China, 200032 Contact: Qilai Long, Ph.D 86-15821758764 long.qilai@zs-hospital.sh.cn 收起 << |
NCT00901927 | Follicular Lymphoma | Phase 2 | Terminated(Study was closed ea... 展开 >>rly due to toxicity) 收起 << | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01249430 | Recurrent Adult Acute Myeloid ... 展开 >>Leukemia Refractory Acute Myeloid Leukemia 收起 << | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 收起 << |
NCT00661492 | Androgen-independent Prostate ... 展开 >>Cancer 收起 << | Phase 2 | Completed | - | - |
NCT00661492 | - | Completed | - | - | |
NCT00059631 | Prostate Cancer | Phase 1 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01839240 | Adult Acute Megakaryoblastic L... 展开 >>eukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia 收起 << | Phase 1 | Active, not recruiting | September 2018 | United States, Illinois ... 展开 >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 收起 << |
NCT01701375 | Relapsed Acute Leukemia ... 展开 >> Refractory Acute Leukemia High-Risk Myelodysplasia 收起 << | Phase 1 | Terminated(Material sponsor wi... 展开 >>thdrew support) 收起 << | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287 United States, New York Weill Cornell Medical Center New York, New York, United States, 10065 收起 << |
NCT00940524 | Leukemia Acut... 展开 >>e Lymphoblastic Leukemia 收起 << | Phase 1 | Completed | - | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT00268242 | Leukemia | Phase 2 | Terminated(If ... 展开 >>tial 18 patients had a CR, the study would be stopped. Only 5 patients (21%) of 24 enrolled patients had a CR so the study was terminated.) 收起 << | - | United States, North Carolina ... 展开 >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 收起 << |
NCT00268242 | - | Terminated(If ... 展开 >>tial 18 patients had a CR, the study would be stopped. Only 5 patients (21%) of 24 enrolled patients had a CR so the study was terminated.) 收起 << | - | - | |
NCT01214317 | Multiple Sclerosis | Not Applicable | Unknown | February 2012 | Iran, Islamic Republic of ... 展开 >> Alahra hospital Isfahan, Iran, Islamic Republic of 收起 << |
NCT01701375 | - | Terminated(Material sponsor wi... 展开 >>thdrew support) 收起 << | - | - | |
NCT01594918 | Metastatic Castration-resistan... 展开 >>t Prostate Cancer 收起 << | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Scottsdale, Arizona, United States, 85259 United States, California UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 收起 << |
NCT02131688 | Malignant Lymphoma | Phase 1 | Unknown | October 2015 | China ... 展开 >> Cancer Hospital ,Chinese Academy of Mddical Sciences Recruiting Beijing, China Contact: Yuankai Shi, Ph.D 010-87788701 Principal Investigator: Yuankai Shi, Ph.D Sub-Investigator: Jianliang Yang, Ph.D 收起 << |
NCT03776279 | Relapsed or Refractory Periphe... 展开 >>ral T-cell and NK/T-cell Lymphoma 收起 << | Phase 2 | Recruiting | December 30, 2020 | China, Guangdong ... 展开 >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Huiqiang Huang, Doctor 020-87343350 收起 << |
NCT02021825 | Neuromyelitis Optica ... 展开 >> Neuromyelitis Optica Spectrum Disorders 收起 << | Phase 4 | Unknown | December 2015 | China, Beijing ... 展开 >> Department of Neurology, Xuanwu Hospital, Capital Medical University Recruiting Beijing, Beijing, China, 100053 Contact: Zheng Liu, Doctor 0086-13910320552 lzwcy2003@aliyun.com Principal Investigator: Huiqing Dong, Doctor 收起 << |
NCT00660036 | Acute Myeloid Leukemia | Phase 1 | Terminated(due to new safety i... 展开 >>nformation) 收起 << | - | United States, Pennsylvania ... 展开 >> University of Pittsburgh Cancer Institute / Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 收起 << |
NCT02596373 | Advanced Recurrent or Metastat... 展开 >>ic Breast Cancer 收起 << | Phase 2 | Recruiting | September 2018 | China ... 展开 >> Fudan University Cancer Hospital Recruiting Shanghai, China Contact: Xichun Hu, Ph.D +8613816110335 xchu2009@hotmail.com Principal Investigator: Xichun Hu, Ph.D 收起 << |
NCT00882076 | Leukemia | Phase 1 | Completed | - | United States, Pennsylvania ... 展开 >> Penn State Hershey Cancer Institute Hershey, Pennsylvania, United States, 17033 收起 << |
NCT00477087 | Prostatic Neoplasms | Phase 2 | Terminated(Low accrual) | - | United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 << |
NCT00203073 | Relapsing Remitting Multiple S... 展开 >>clerosis 收起 << | Phase 2 | Completed | - | - |
NCT01842672 | Acute Lymphoblastic Leukemia ... 展开 >> Acute Myelogenous Leukemia Lymphoblastic Lymphoma Diffuse Large B-cell Lymphoma Burkitt Lymphoma/Leukemia 收起 << | Phase 1 Phase 2 | Recruiting | December 2018 | United States, New York ... 展开 >> New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Mitchell Cairo, MD 914-594-3650 mitchell_cairo@nymc.edu Contact: Lauren Harrison, MSN 617-285-7844 lauren_harrison@nymc.edu United States, North Carolina Levine Children's Hospital Recruiting Charlotte, North Carolina, United States, 28204 Contact: Javier Oesterheld, MD 704-381-9900 Javier.Oesterheld@carolinashealthcare.org 收起 << |
NCT02043756 | Neoplasms | Phase 1 | Completed | - | - |
NCT01627938 | Multiple Sclerosis | Phase 2 | Unknown | April 2016 | Germany ... 展开 >> Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum Bochum, Germany, 44791 收起 << |
NCT00477087 | - | Terminated(Low accrual) | - | - | |
NCT02044354 | Metastatic Castration-resistan... 展开 >>t Prostate Cancer 收起 << | Phase 3 | Active, not recruiting | April 2018 | France ... 展开 >> Gustave Roussy Villejuif, Val de Marne, France, 94805 收起 << |
NCT00060684 | Lymphoma, Low-Grade ... 展开 >> Lymphoma, Small Lymphocytic Lymphoma, Mixed-Cell, Follicular Lymphoma, Small Cleaved-Cell, Follicular 收起 << | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Arizona Clinical Research Center Tucson, Arizona, United States, 85712 United States, Maryland Greater Baltimore Medical Center Baltimore, Maryland, United States, 21204 United States, New Mexico New Mexico Onc/Hem Consultants, Inc. Albuquerque, New Mexico, United States, 87109 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00003650 | Lymphoma | Phase 3 | Unknown | - | France ... 展开 >> Centre Leon Berard Lyon, France, 69373 收起 << |
NCT00002700 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 3 | Completed | - | - |
NCT00003728 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 3 | Unknown | - | Belgium ... 展开 >> Ziekenhuis Netwerk Antwerpen Middelheim Antwerp, Belgium, 2020 Hopital Universitaire Des Enfants Reine Fabiola Brussels, Belgium, 1020 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium, 1090 Ghent University Ghent, Belgium, B-9000 Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Centre Hospitalier Regional de la Citadelle Liege, Belgium, 4000 Clinique de l'Esperance Montegnee, Belgium, 4420 France Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 CHU de Caen Caen, France, 14033 CHU de Grenoble - Hopital de la Tronche Grenoble, France, 38043 Hopital Debrousse Lyon, France, 69322 Hopital Arnaud de Villeneuve Montpellier, France, 34059 CHR Hotel Dieu Nantes, France, 44035 Hopital de l'Archet CHU de Nice Nice, France, F-06202 CHU - Hopital Robert Debre Paris, France, 75019 Hopital Jean Bernard Poitiers, France, 86021 Hopital Americain Reims, France, 51092 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants Toulouse, France, 31026 Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Instituto Portugues de Oncologia Centro do Porto, SA Porto, Portugal, 4200 收起 << |
NCT00002701 | Leukemia | Phase 3 | Unknown | - | - |
NCT00003215 | Lymphoma | Phase 3 | Completed | - | Austria ... 展开 >> Allgemeines Krankenhaus der Stadt Wien Vienna, Austria, A-1090 Germany Dr. Horst-Schmidt-Kliniken Wiesbaden, Germany, D-65199 Greece Saint Savvas Cancer Hospital of Athens Athens, Greece, 11522 Italy European Institute of Oncology Milano, Italy, 20141 Switzerland Universitatsspital-Basel Basel, Switzerland, CH-4031 Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Inselspital, Bern Bern, Switzerland, CH-3010 Ratisches Kantons und Regionalspital Chur, Switzerland, CH-7000 Hopital Cantonal Universitaire de Geneve Collonge-Bellerive, Switzerland, CH-1245 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, 1011 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Klinik Hirslanden Zurich, Switzerland, CH-8008 收起 << |
NCT00005802 | Leukemia | Phase 1 Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT00005985 | Lymphoma | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00317096 | Lymphoma, Follicular ... 展开 >> Lymphoma, Low-Grade Lymphoma, Intermediate-Grade 收起 << | Phase 3 | Active, not recruiting | June 2021 | Germany ... 展开 >> German Low Grade Study Group (Glsg) Munich, Germany, D-81377 收起 << |
NCT00002531 | Leukemia | Phase 2 | Unknown | - | Germany ... 展开 >> Klinikum der J.W. Goethe Universitaet Frankfurt, Germany, D-60590 收起 << |
NCT00003893 | Breast Cancer | Phase 3 | Completed | - | United Kingdom ... 展开 >> Queen Elizabeth Hospital at University of Birmingham Birmingham, England, United Kingdom, B15 2TH 收起 << |
NCT00005987 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 2 | Terminated(Withdrawn because t... 展开 >>reatment guidelines changed) 收起 << | - | United States, Minnesota ... 展开 >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00003436 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 3 | Completed | - | United Kingdom ... 展开 >> Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX 收起 << |
NCT00002658 | Leukemia Neut... 展开 >>ropenia 收起 << | Phase 3 | Unknown | - | United Kingdom ... 展开 >> University of Wales College of Medicine Cardiff, Wales, United Kingdom, CF14 4XN 收起 << |
NCT00002517 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 3 | Completed | - | Belgium ... 展开 >> Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 Hopital Universitaire Des Enfants Reine Fabiola Brussels, Belgium, 1020 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium, 1090 Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Centre Hospitalier Regional de la Citadelle Liege, Belgium, 4000 Clinique de l'Esperance Montegnee, Belgium, 4420 France Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 CHU de Caen Caen, France, 14033 CHR de Grenoble - La Tronche Grenoble, France, 38043 Centre Hospitalier Regional de Lille Lille, France, 59037 Hopital Debrousse Lyon, France, 69322 Hopital Arnaud de Villeneuve Montpellier, France, 34295 CHR Hotel Dieu Nantes, France, 44093 Centre Antoine Lacassagne Nice, France, 06189 Hopital Robert Debre Paris, France, 75019 Institut Curie - Section Medicale Paris, France, 75248 Hopital Jean Bernard Poitiers, France, 86021 Hopital Americain Reims, France, 51092 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants (Purpan Enfants) Toulouse, France, 31026 Portugal Hospital Escolar San Joao Porto, Portugal, 4200 收起 << |
NCT00002549 | Leukemia | Phase 3 | Unknown | - | - |
NCT00070174 | Leukemia | Phase 2 | Completed | - | - |
NCT00032149 | Lymphoma | Phase 1 Phase 2 | Unknown | - | United Kingdom ... 展开 >> Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN St. Georges, University of London London, England, United Kingdom, SW17 ORE King's College Hospital London, England, United Kingdom, W1T 4TJ Edinburgh Cancer Centre at Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU 收起 << |
NCT00317408 | Lymphoma | Not Applicable | Unknown | - | - |
NCT00005823 | Leukemia Myel... 展开 >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 3 | Completed | - | United Kingdom ... 展开 >> Queen Elizabeth Hospital at University of Birmingham Birmingham, England, United Kingdom, B15 2RR University College Hospital London, England, United Kingdom, WC1E 6AU University Hospital of Wales Cardiff, Wales, United Kingdom, CF14 4XN 收起 << |
NCT00550992 | Leukemia | Not Applicable | Unknown | - | United States, Massachusetts ... 展开 >> Children's Hospital Boston Recruiting Boston, Massachusetts, United States, 02215 Contact: Lewis B. Silverman, MD 617-632-5285 United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Clinical Trials Office - St. Jude Children's Research Hospital 901-595-4644 United States, Texas M. D. Anderson Cancer Center at University of Texas Recruiting Houston, Texas, United States, 77030-4009 Contact: Clinical Trials Office - M. D. Anderson Cancer Center at the U 713-792-3245 United States, Washington Children's Hospital and Regional Medical Center - Seattle Recruiting Seattle, Washington, United States, 98105 Contact: Blythe Thomson, MD 206-987-2106 Austria St. Anna Children's Hospital Recruiting Vienna, Austria, A-1090 Contact: Georg Mann, MD 43-1-4017-1250 Belgium Hopital Universitaire Des Enfants Reine Fabiola Recruiting Brussels, Belgium, 1020 Contact: Alice Ferster, MD 32-2-477-2678 aferster@ulb.ac.be Czech Republic University Hospital Motol Recruiting Prague, Czech Republic, 150 06 Contact: Jan Stary, MD 420-2-2443-6401 jan.stary@lfmotol.cuni.cz France CHR Hotel Dieu Recruiting Nantes, France, 44093 Contact: Francoise Mechinaud, MD 33-1-4249-9046 Germany University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Gritta Janka-Schaub 49-404-2803-2580 Medizinische Hochschule Hannover Recruiting Hannover, Germany, D-30625 Contact: Martin Schrappe, MD, PhD 49-511-532-6713 Italy Nuovo Ospedale San Gerardo at University of Milano-Bicocca Recruiting Monza, Italy, 20052 Contact: Andrea Biondi, MD 39-039-233-3661 biondi@galactica.it Netherlands Erasmus MC - Sophia Children's Hospital Recruiting Rotterdam, Netherlands, 3015 GJ Contact: Rob Pieters, MD, MSC, PhD 31-10-463-6691 rob.pieters@erasmusmc.nl United Kingdom Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Phil Ancliff, MD 44-20-7829-8831 收起 << |
NCT00199069 | Adult Acute Lymphocytic Leukem... 展开 >>ia 收起 << | Phase 4 | Completed | - | Germany ... 展开 >> University Hospital, Medical Dept. II Frankfurt, Germany 收起 << |
NCT00002905 | Lymphoma | Phase 2 | Unknown | - | Italy ... 展开 >> Centro di Riferimento Oncologico - Aviano Aviano, Italy, 33081 收起 << |
NCT00004197 | Lymphoma | Phase 2 | Completed | - | United States, California ... 展开 >> Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-3330 收起 << |
NCT00499018 | Diffuse Large B-Cell Lymphoma ... 展开 >> IPI≥2 收起 << | Phase 3 | Unknown | September 2013 | - |
NCT00526305 | Acute Lymphoblastic Leukemia | Phase 4 | Completed | - | - |
NCT00005998 | Lymphoma | Phase 2 | Withdrawn(Withdrawn because st... 展开 >>udy never enrolled patients) 收起 << | - | - |
NCT00458848 | Leukemia | Phase 2 | Completed | - | - |
NCT02523976 | Acute,Leukemia, Lymphoid | Phase 2 | Enrolling by invitation | August 2019 | China, Tianjin ... 展开 >> Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin, China, 300020 收起 << |
NCT00002719 | Leukemia Neut... 展开 >>ropenia 收起 << | Phase 3 | Completed | - | Italy ... 展开 >> Azienda Policlinico Umberto Primo Rome, Italy, 00161 收起 << |
NCT00003957 | Lymphoma | Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 收起 << |
NCT00840684 | Leukemia | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 收起 << |
NCT03736382 | Obstructive Sleep Apnea | Not Applicable | Recruiting | October 2020 | United States, Michigan ... 展开 >> John D Dingell VA Medical Center Recruiting Detroit, Michigan, United States, 48201 Contact: Jason H Mateika, Ph.D. 313-576-4481 am1819@wayne.edu Contact: Raichel M Alex, Ph.D. 313-576-4454 gm9041@wayne.edu Principal Investigator: Jason H Mateika, Ph.D. Wayne State University Recruiting Detroit, Michigan, United States, 48201 Contact: Jason H Mateika, Ph.D. 313-576-4481 am1819@wayne.edu Contact: Raichel M Alex, Ph.D. 313-576-4454 gm9041@wayne.edu Principal Investigator: Jason H Mateika, Ph.D. 收起 << |
NCT00556127 | Diffuse Large B-Cell Lymphoma ... 展开 >> POOR PROGNOSIS 收起 << | Phase 2 | Completed | - | Italy ... 展开 >> Az. Ospedaliera SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy Ospedale Regionale, Divisione di Oncologia, Aosta, Italy Azienda Ospedaliera Ospedale Policlinico Consorziale Bari, Italy Osp. degli Infermi Biella, Italy Spedali Civili Brescia, Italy Centro Trapianti Midollo Osseo, P.O. Businco Cagliari, Italy Ospedale S. Gerardo Monza, Italy Osp. maggiore della Carità Novara, Italy Università degli Studi Policlinico Monteluce Perugia, Italy Divisione di Medicina, Ospedale Generale E. Agnelli, Pinerolo Torino, Italy Istituto per la Ricerca e la Cura del Cancro, Candiolo Torino, Italy Osp. S. Giovanni Battista "Molinette" Torino, Italy Ospedale di Chivasso e Ivrea Torino, Italy Stabilimento Ospedaliero Ciriè - Torino, Italy 收起 << |
NCT03250338 | Relapsed/Refractory Acute Myel... 展开 >>oid Leukemia With FLT3 Activating Mutations 收起 << | Phase 3 | Recruiting | October 2021 | United States, California ... 展开 >> UC Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Brian Jonas, MD 916-734-5959 United States, Kansas Kansas University Recruiting Kansas City, Kansas, United States, 666160 Contact: Sunil Abhyankar, MD Principal Investigator: Sunil Abhyankar, MD United States, Michigan Karmanos Cancer Center Recruiting Detroit, Michigan, United States, 48201 Contact: Jay Yang, MD yangj@karmanos.org Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Yue Guo, MD Principal Investigator: Yue Guo, MD United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Eunice Wang, MD Principal Investigator: Eunice Wang, MD 收起 << |
NCT00071799 | Myelodysplastic Syndromes | Phase 3 | Completed | - | - |
NCT02339740 | Acute Promyelocytic Leukemia W... 展开 >>ith PML-RARA 收起 << | Phase 3 | Recruiting | - | - |
NCT02907359 | Myelodysplastic Syndromes ... 展开 >> Leukemia, Myelomonocytic, Chronic 收起 << | Phase 3 | Recruiting | December 2019 | - |
NCT02101853 | B Acute Lymphoblastic Leukemia | Phase 3 | Recruiting | - | - |
NCT02665065 | Acute Myeloid Leukemia ... 展开 >> Leukemia, Acute Myeloid Myeloid Leukemia, Acute Leukemia, Myeloid, Acute Acute Myelogenous Leukemia Leukemia, Acute Myelogenous Myelogenous Leukemia, Acute 收起 << | Phase 3 | Recruiting | June 2020 | United States, Arizona ... 展开 >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States United States, Illinois Loyola University Medical Center Recruiting Maywood, Illinois, United States United States, Kansas The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Stony Brook University Recruiting Stony Brook, New York, United States United States, Ohio University Hospital of Cleveland Seidman Cancer Center Recruiting Cleveland, Ohio, United States The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States United States, Texas Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States MD Anderson Cancer Center Recruiting Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States Canada, Ontario University of Ottawa Recruiting Ottawa, Ontario, Canada 收起 << |
NCT00866918 | Childhood Acute Promyelocytic ... 展开 >>Leukemia (M3) Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies 收起 << | Phase 3 | Completed | - | - |
NCT03165851 | - | Completed | - | China, Tianjin ... 展开 >> InstituteHBDH Tianjin, Tianjin, China, 300020 收起 << | |
NCT00869284 | Lymphoma | Phase 2 | Completed | - | France ... 展开 >> Emmanuel Gyan Tours, France, 37000 收起 << |
NCT00866918 | - | Completed | - | - | |
NCT00774826 | Follicular Lymphoma | Phase 3 | Unknown | March 2014 | - |
NCT02421939 | Leukemia, Acute Myeloid (AML) | Phase 3 | Active, not recruiting | December 2020 | - |
NCT00853008 | Acute Lymphoblastic Leukemia | Phase 4 | Active, not recruiting | January 2019 | Spain ... 展开 >> Hospital General Alicante, Spain Hospital Germans Trias i Pujol Badalona, Spain Clínica Teknon Barcelona, Spain Hospital Clínic i Provincial Barcelona, Spain Hospital de Sant Pau Barcelona, Spain Hospital Duran y Reynals Barcelona, Spain Hospital Vall d'Hebrón Barcelona, Spain Hospital General Castellón, Spain Hospital San Pedro de Alcántara Cáceres, Spain Hospital Puerta del Mar Cádiz, Spain Hospital Josep Trueta Girona, Spain Hospital Universitario Guadalajara, Spain Hospital Juan Canalejo La Coruña, Spain Hospital Xeral Lugo, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico Universitario Madrid, Spain Hospital de Fuenlabrada Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospital Carlos Haya Málaga, Spain Hospital Virgen de la Victoria Málaga, Spain Hospital Central de Asturias Oviedo, Spain Hospital Son Llàtzer Palma de Mallorca, Spain Clínica Universitaria de Navarra Pamplona, Spain Hospital Parc Taulí Sabadell, Spain Hospital Clínico Universitario Salamanca, Spain Hospital Marqués de Valdecilla Santander, Spain Hospital Xeral Santiago, Spain Hospital Virgen del Rocio Sevilla, Spain Hospital Joan XXIII Tarragona, Spain Hospital Mútua de Terrassa Terrassa, Spain Hospital Clínico Universitario Valencia, Spain Hospital Dr Pesset Valencia, Spain Hospital General Valencia, Spain Hospital La Fe Valencia, Spain Hospital Clínico Valladolid, Spain Hospital Virgen de la Concha Zamora, Spain Hospital Lozano Blesa Zaragoza, Spain 收起 << |
NCT02788201 | Urothelial Carcinoma ... 展开 >> Bladder Cancer Urinary Bladder Neoplasms 收起 << | Phase 2 | Recruiting | July 1, 2020 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT02039726 | AML | Phase 3 | Active, not recruiting | July 2019 | - |
NCT00003080 | Ovarian Cancer | Phase 1 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT00052299 | Leukemia | Phase 3 | Completed | - | - |
NCT03150004 | Acute Myeloid Leukemia | Phase 2 | Recruiting | June 1, 2020 | United States, Wisconsin ... 展开 >> Froedtert & the Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Medical College of Wisconsin Clinical Cancer Center 414-805-8900 cccto@mcw.edu 收起 << |
NCT00107354 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 1 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT00586755 | Mantle Cell Lymphoma | Phase 2 | Completed | - | - |
NCT00071799 | - | Completed | - | - | |
NCT00151255 | Acute Myeloid Leukemia | Phase 3 | Completed | - | Austria ... 展开 >> Department of Hematology/Oncology, University Hospital of Innsbruck Innsbruck, Austria, 6020 Department of Internal Medicine I, Krankenhaus der Barmherzigen Schwestern Linz, Austria, 4010 Medical Department III, St. Johann Hospital Salzburg, Austria, 5020 Center of hematology and oncology, Hanusch Hospital Wien, Austria, 1140 Germany Department of Internal Medicine I, Central Hospital of Augsburg Augsburg, Germany, 86856 Department of General Internal Medicine, University Hospital of Bonn Bonn, Germany, 53127 Medical Department I, Hospital of Bremen-Mitte Bremen, Germany, 28177 Department of Hematology and Oncology, Hospital Essen-Süd, Ev. Hospital of Essen-Werden Essen, Germany, 45239 Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst Frankfurt, Germany, 65929 Medical Department IV, University Hospital of Giessen Giessen, Germany, 35392 Department of Internal Medicine, Wilhelm-Anton Hospital gGmbH Goch, Germany, 47574 Centre of Internal Medicine, University Hospital of Göttingen Göttingen, Germany, 37075 Department of Oncology and Hematology, University Hospital Eppendorf Hamburg, Germany, 20246 Medical Department II, General Hospital Altona Hamburg, Germany, 22763 Medical Department III, Hospital of Hanau Hanau, Germany, 63450 Medical Department III, Hospital of Hannover-Siloah Hannover, Germany, 30449 Department of Internal Medicine I, University Hospital of Saarland Homburg, Germany, 66421 Medical Department II, City Hospital Karlsruhe gGmbH Karlsruhe, Germany, 76133 Medical Department II, University Hospital of Kiel Kiel, Germany, 24116 Department of Internal Medicine/Hematology and Oncology, Caritas Hospital Lebach Lebach, Germany, 66822 Department of Hematology/Oncology, Clinical Center of Lüdenscheid Lüdenscheid, Germany, 58515 Medical Department III, Clinical Center Rechts der Isar München, Germany, 81675 Department of Hematology and Oncology, Clinical Center of Oldenburg gGmbH Oldenburg, Germany, 26133 Department of Hematology and Oncology/Caritas Hospital St. Theresa Saarbrücken, Germany, 66113 Department of Oncology, Clinical Center of Stuttgart Stuttgart, Germany, 70174 Medical Department II, Diakonie Hospital Stuttgart, Germany, 70176 I. Medical Department, Hospital of Barmerzigen Brüder Trier, Germany, 54292 Medical Center II - Hematology/Oncology, Clinical Center Villingen-Schwenningen Villingen - Schwenningen, Germany, 78050 Medical Department I, Helios Hospital Wuppertal Wuppertal, Germany, 42283 收起 << |
NCT01371981 | Acute Myeloid Leukemia ... 展开 >> Leukemia Cutis Myeloid Neoplasm Myeloid Sarcoma Untreated Adult Acute Myeloid Leukemia Untreated Childhood Myeloid Neoplasm 收起 << | Phase 3 | Active, not recruiting | - | - |
NCT00006122 | Leukemia | Phase 2 | Completed | - | Austria ... 展开 >> Innsbruck Universitaetsklinik Innsbruck, Austria, A-6020 Belgium A.Z. St. Jan Brugge, Belgium, 8000 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 CHU Sart-Tilman Liege, Belgium, B-4000 Croatia University Hospital Rebro Zagreb, Croatia, 41000 France Hopital Edouard Herriot Lyon, France, 69437 Hotel Dieu de Paris Paris, France, 75181 Hopital Necker Paris, France, 75743 Germany Medizinische Klinik und Poliklinik Heidelberg, Germany, D-69115 Eberhard Karls Universitaet Tuebingen, Germany, D-72076 Italy Ospedale Generale Regionale Bolzano, Italy, 39100 Ospedali Riuniti Reggio Calabria, Italy, 89100 Ospedale San Eugenio Rome, Italy, 00144 Azienda Policlinico Umberto Primo Rome, Italy, 00161 Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Rome, Italy, 00168 Netherlands Groot Ziekengasthuis 's-Hertogenbosch 's-Hertogenbosch, Netherlands, 5211 NL Leiden University Medical Center Leiden, Netherlands, 2300 CA University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB 收起 << |
NCT01497002 | Acute Myeloid Leukaemia | Phase 3 | Unknown | December 2013 | Germany ... 展开 >> University of Leipzig, Hematology Recruiting Leipzig, Germany, 04103 Principal Investigator: Dietger Niederwieser 收起 << |
NCT00003032 | Breast Cancer | Phase 3 | Completed | - | Canada, Alberta ... 展开 >> Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia BC Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick Moncton Hospital Moncton, New Brunswick, Canada, E1C 6ZB Saint John Regional Hospital Saint John, New Brunswick, Canada, E2L 4L2 Canada, Newfoundland and Labrador Newfoundland Cancer Treatment and Research Foundation St. Johns, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Nova Scotia Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario William Osler Health Centre Brampton, Ontario, Canada, L6W 2Z8 Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Ottawa Regional Cancer Centre - General Campus Ottawa, Ontario, Canada, K1H 1C4 Hotel Dieu Hospital - St. Catharines St. Catharines, Ontario, Canada, L2R 5K3 Northeastern Ontario Regional Cancer Centre, Sudbury Sudbury, Ontario, Canada, P3E 5J1 Northwestern Ontario Regional Cancer Centre, Thunder Bay Thunder Bay, Ontario, Canada, P7A 7T1 Toronto Sunnybrook Regional Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Humber River Regional Hospital Weston, Ontario, Canada, M9N 1N8 Cancer Care Ontario - Windsor Regional Cancer Centre Windsor, Ontario, Canada, N8W 2X3 Canada, Prince Edward Island Queen Elizabeth Hospital, PEI Charlottetown, Prince Edward Island, Canada, C1A 8T5 Canada, Quebec L'Hotel Dieu de Levis Levis, Quebec, Canada, G6V 3Z1 Centre Hospitalier de l'Universite de Montreal Montreal, Quebec, Canada, H2L-4M1 McGill University Department of Oncology Montreal, Quebec, Canada, H2W 1S6 Hotel Dieu de Montreal Montreal, Quebec, Canada, H2W 1T8 Centre Hospitalier Universitaire de Quebec, Pavillion de Quebec Quebec City, Quebec, Canada, G1R 2J6 收起 << |
NCT01039363 | Acute Myeloid Leukemia | Phase 2 | Unknown | - | Korea, Republic of ... 展开 >> Samsung Medical Center Not yet recruiting Seoul, Korea, Republic of, 135-710 Principal Investigator: Dong Hwan Won, M.D.,Ph.D. 收起 << |
NCT03616470 | Acute Myeloid Leukemia | Phase 3 | Recruiting | December 2023 | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Daniel J DeAngelo, MD, PhD 617-632-2645 Daniel_Deangelo@dfci.harvard.edu Principal Investigator: Daniel DeAngelo, MD, PhD United States, New York University of Rochester Medical Center Recruiting Rochester, New York, United States, 14642 Contact: Brandon DeLorme 585-275-5295 Brandon_Delorme@URMC.Rochester.edu Principal Investigator: Jane Liesveld, MD United States, Ohio The Ohio State University Wexner Medical Center and James Cancer Hospital Recruiting Columbus, Ohio, United States, 43210 Contact: Jennifer Dienno 614-293-0752 Jennifer.Dienno@osumc.edu Principal Investigator: Alice Mims, MD United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Naval Daver, MD 713-794-4392 NDaver@mdanderson.org Principal Investigator: Naval Daver, MD United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Niall Curley 206-606-1231 Ncurley8@seattlecca.org Principal Investigator: Pamela Becker, MD, PhD 收起 << |
NCT00146120 | Acute Myeloid Leukemia | Phase 3 | Completed | - | Austria ... 展开 >> Department of Hematology / Oncology, University Hospital of Innsbruck Innsbruck, Austria, 6020 III Medical Department, Hematology and Oncology Center, Hanuschhospital Wien Wien, Austria, 1140 Germany Department of General Internal Medicine, University Hospital of Bonn Bonn, Germany, 53127 Department of Internal Medicine Hematology, Heinrich-Heine University Düsseldorf, Germany, 40225 Department of Interial Medicine III, City Hospital Frankfurt Am Main - Höchst Frankfurt, Germany, 65927 Medical Department IV, University of Gießen Gießen, Germany, 35392 Department of Interial Medicine, Wilhelm-Anton-Hospital Goch Goch, Germany, 47574 Centre of Interial Medicine, University of Göttingen Göttingen, Germany, 37075 Medical Department III of Hematology and Oncology, General Hospital Altona Hamburg, Germany, 22763 Department of Interial Medicine V, University of Heidelberg Heidelberg, Germany, 69120 Department of Interial Medicine I, University Hospital of Saarland Homburg, Germany, 66421 Medical Department II, City Hospital Karlsruhe gGmbH Karlsruhe, Germany, 76133 Medical Department II, University Hospital of Kiel Kiel, Germany, 24116 Department of Interial Medicine /Hematology and Oncology, Caritas Hospital Lebach Lebach, Germany, 66822 I. Medical Department, City Hospital München-Schwabing München, Germany, 80804 Medical Department III, Clinical Center rechts der Isar München, Germany, 81675 Department of Hematology and Oncology, City Hospital Neunkirchen gGmbH Neunkirchen, Germany, 66538 Department of Hematology and Oncology, Clinical Center of Oldenburg gGmbH Oldenburg, Germany, 26133 Department of Hematologie and Oncology, Caritas Hospital St. Theresa Saarbrücken Saarbrücken, Germany, 66113 Clinikal Cetner of Stuttgart, Center of Oncology Stuttgart, Germany, 70174 Medical Department I, Clinical Center of Stuttgart Stuttgart, Germany, 70191 Hospital of Barmherzige Brüder, I Medical Department Trier, Germany, 54292 收起 << |
NCT02644044 | To Evaluate the Effect of Ther... 展开 >>apy With IT MTX on the Disease Course of Patients With Progressive MS 收起 << | Early Phase 1 | Unknown | January 2018 | - |
NCT00003602 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 3 | Unknown | - | United Kingdom ... 展开 >> Newcastle Upon Tyne Hospitals NHS Trust Newcastle-Upon-Tyne, England, United Kingdom, NE7 7DN 收起 << |
NCT00006045 | Leukemia | Phase 3 | Unknown | - | - |
NCT00273364 | Multiple Sclerosis | Phase 2 | Active, not recruiting | December 2018 | United States, Illinois ... 展开 >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 收起 << |
NCT02288936 | Hormone-refractory Prostate Ca... 展开 >>ncer 收起 << | Phase 2 | Active, not recruiting | January 2019 | Spain ... 展开 >> Hospital Universitari Germans Trias I Pujol de Badalona Badalona, Barcelona, Spain, 08916 Hospital Universitari Son Espases Palma de Mallorca, Islas Baleares, Spain, 07120 Hospital Clinic I Provincial de Barcelona Barcelona, Spain, 08036 Hospital Parc Taulí Barcelona, Spain Complejo Hospitalario Regional Reina Sofía Córdoba, Spain, 14004 Complejo Asistencial Universitario de Leon León, Spain, 24080 Hospital Universitario Lucus Augusti Lugo, Spain, 27003 Hospital Ramón Y Cajal Madrid, Spain, 28034 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital General Universitario J.M. Morales Meseguer Murcia, Spain, 30008 Complejo Hospitalario de Especialidades Virgen de La Victoria Málaga, Spain, 29010 Complexo Hospitalario Universitario de Ourense Ourense, Spain, 32005 Complejo Hospitalario Regional Virgen Del Rocio Sevilla, Spain, 41013 Fundación Instituto Valenciano de Oncologia Valencia, Spain, 46009 Hospital Universitario Miguel Servet Zaragoza, Spain, 50009 收起 << |
NCT03356912 | Prostate Cancer ... 展开 >> Castration-resistant Prostate Cancer 收起 << | Phase 2 | Enrolling by invitation | May 4, 2021 | Italy ... 展开 >> University Federico II of Naples Naples, Italy 收起 << |
NCT00088530 | Lymphoma, Non-Hodgkin | Phase 3 | Completed | - | - |
NCT02028650 | - | Completed | - | China, Beijing ... 展开 >> Affiliated Hospital of Academy of Military Medical Sciences Beijing, Beijing, China, 100071 收起 << | |
NCT00088530 | - | Completed | - | - | |
NCT02920008 | Acute Myeloid Leukemia | Phase 3 | Active, not recruiting | December 2019 | - |
NCT00006250 | Lymphoma | Phase 3 | Unknown | - | - |
NCT00031187 | Prostatic Neoplasms | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, Arkansas Highlands Oncology Group Springdale, Arkansas, United States, 72764 United States, California West Los Angeles - VA Healthcare Center Los Angeles, California, United States, 90073 VA Medical Center of Palo Alto Palo Alto, California, United States, 94304 Sharp HealthCare, Sidney Kimmel Cancer Center San Diego, California, United States, 92121 United States, Connecticut Bendheim Cancer Center Greenwich, Connecticut, United States, 06830 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Broward Oncology Associates Ft. Lauderdale, Florida, United States, 33308 Innovative Medical Research of South Florida Miami Shores, Florida, United States, 33138 United States, Michigan St. Joseph Mercy Oakland Hospital Pontiac, Michigan, United States, 33308 United States, Virginia Arlington Fairfax Hematology-Oncology, P.C. Arlington, Virginia, United States, 22205 收起 << |
NCT00577161 | Non-Hodgkin's Lymphoma | Phase 3 | Terminated(closed to enrollmen... 展开 >>t) 收起 << | July 2012 | United States, Alabama ... 展开 >> Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States, 35661 United States, California Ventura County Hematology Oncology Specialist Oxnard, California, United States, 93030 United States, Missouri Capitol Comprehensive Cancer Care Jefferson City, Missouri, United States, 65109 Heartland Hematology Oncology Associates Kansas City, Missouri, United States, 64118 United States, New York Cancer Care Center New Albany, New York, United States, 47150 Interlakes Foundation, Inc. Rochester, New York, United States, 14623 United States, Ohio Hematology Oncology Consultants Columbus, Ohio, United States, 43235 United States, Utah Utah Hematology Oncology, P.C. Ogden, Utah, United States, 84403 收起 << |
NCT00002565 | Lymphoma | Phase 3 | Completed | - | United States, Texas ... 展开 >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Brazil Faculdade de Medicina do ABC Sao Paulo, Brazil, 01224--010 Chile Clinica Alemana Santiago, Chile, 5951 收起 << |
NCT01779479 | Primary Breast Cancer | Phase 2 | Completed | - | Germany ... 展开 >> Luisenkrankenhaus Düsseldorf, Germany, 40235 收起 << |
NCT01541007 | Metastatic Castration Resistan... 展开 >>t Prostate Cancer 收起 << | Phase 2 | Completed | - | Sweden ... 展开 >> Deapartment of Oncology Karolinska University Hospital Stockholm, Sweden, 171 76 收起 << |
NCT00712582 | Non-Hodgkin's Lymphoma | Phase 2 | Completed | - | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT02688140 | Acute Promyelocytic Leukemia | Phase 3 | Recruiting | January 2022 | France ... 展开 >> French-Belgian-Swiss APL study group Not yet recruiting Multiple Locations, France Contact: Pierre Fenaux, Prof. Dr. pierre.fenaux@avc.ap-hop-paris.fr Contact: Lionel Ades, Dr. lionel.ades@sls.aphp.fr Germany AML-CG study group Recruiting Multiple Locations, Germany Contact: Eva Lengfelder, Prof. Dr. Eva.Lengfelder@umm.de AML-SG study group Recruiting Multiple Locations, Germany Contact: Richard F. Schlenk, Prof. Dr. Richard.Schlenk@uniklinik-ulm.de OSHO study group Recruiting Multiple Locations, Germany Contact: Dietger Niederwieser, Prof. Dr. Dietger.Niederwieser@medizin.uni-leipzig.de SAL study group Recruiting Multiple Locations, Germany Contact: Uwe Platzbecker, Prof. Dr. +49 351 458 ext 3192 uwe.platzbecker@uniklinikum-dresden.de Contact: Michaela Sauer +49 351 458 ext 3192 michaela.sauer@uniklinikum-dresden.de Italy GIMEMA study group Not yet recruiting Multiple Locations, Italy Contact: Francesco Lo-Coco, Prof. Dr. Francesco.lo.coco@uniroma2.it Contact: Fabio Efficace, Dr. f.efficace@gimema.it Netherlands HOVON study group Not yet recruiting Multiple Locations, Netherlands Contact: Edo Vellenga, Prof. Dr. e.vellenga@umcg.nl Spain PETHEMA study group Not yet recruiting Multiple Locations, Spain Contact: Miguel A. Sanz, Prof. Dr. sanz_mig@gva.es Contact: Pau Montesinos, Prof. Dr. montesinos_pau@gva.es 收起 << |
NCT00028899 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 1 | Completed | - | - |
NCT03164057 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndromes 收起 << | Phase 2 | Recruiting | June 2027 | United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Weili Sun, MD,PhD 800-826-4673 weilisun@coh.org Principal Investigator: Weili Sun, MD,PhD Children's Hospital of Central California Recruiting Madera, California, United States, 93636 Contact: Faisal Razzaqi, MD 866-353-5437 frazzaqi@valleychildrens.org Principal Investigator: Faisal Razzaqi, MD Children's Hospital of Orange County Recruiting Orange, California, United States, 92968 Contact: Jamie Frediani, MD 714-509-4348 jfrediani@choc.org Principal Investigator: Jamie Frediani, MD Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD 650-497-8953 lacayon@stanford.edu Principal Investigator: Norman J. Lacayo, MD Rady Children's Hospital and Health Center Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD 858-966-5983 dschiff@chsd.org Principal Investigator: Deborah Schiff, MD United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD 866-278-5833 tanja.gruber@stjude.org Contact: Referral Office 866-278-5833 referralinfo@stjude.org Principal Investigator: Tanja A. Gruber, MD, PhD United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD 682-885-4007 kenneth.heym@cookchildrens.org Principal Investigator: Kenneth M. Heym, MD 收起 << |
NCT00278993 | Prostate Cancer | Phase 2 | Completed | - | United States, Colorado ... 展开 >> Dr. Robert Jotte Denver, Colorado, United States, 80218 United States, Florida Melbourne Internal Medicine Associates Melbourne, Florida, United States, 32901 Ocala Oncology Center PL Ocala, Florida, United States, 34474 United States, Indiana Central Indiana Cancer Centers Indianapolis, Indiana, United States, 46227 United States, Minnesota Minnesota Hematology Oncology Burnsville, Minnesota, United States, 33557 United States, Missouri Missouri Cancer Associates Columbia, Missouri, United States, 65201 United States, New York New York Oncology Hematology, P.C. Albany, New York, United States, 12208 St. Luke's Roosevelt Hospital Center New York, New York, United States, 10019 Columbia University Medical Center New York, New York, United States, 10032 United States, North Carolina Raleigh Hematology Oncology Associates PL Raleigh, North Carolina, United States, 27607 United States, Texas US Oncology Dallas, Texas, United States, 75204 Mary Crowley Medical Research Center Dallas, Texas, United States, 75246 El Paso Cancer Treatment Center El Paso, Texas, United States, 79915 Texas Oncology PA Fort Worth, Texas, United States, 76104 Texas Oncology PA Tyler, Texas, United States, 75702 Tyler Cancer Center Tyler, Texas, United States, 75702 Deke Slayton Cancer Center Webster, Texas, United States, 77598 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23505 收起 << |
NCT02072811 | Acute Myeloid Leukemia | Phase 3 | Unknown | February 2018 | Poland ... 展开 >> Copernicus Memorial Hospital Recruiting Lodz, Poland, 93-510 Principal Investigator: Agnieszka Wierzbowska, Dr hab. n. med. 收起 << |
NCT00278993 | - | Completed | - | - | |
NCT03257241 | Acute Myeloid Leukemia | Phase 3 | Recruiting | December 31, 2020 | Poland ... 展开 >> Medical University of Bialystok Clinical Hospital Recruiting Białystok, Poland, 15-276 Contact: Jarosław Piszcz, Dr Markiewicz Memorial Oncology Center Brzozow Recruiting Brzozów, Poland, 36-200 Contact: Andrzej Pluta, Dr University Clinical Centre in Gdansk Recruiting Gdańsk, Poland, 80-210 Contact: Maria Bieniaszewska, Dr Holycross Cancer Center Recruiting Kielce, Poland, 25-001 Contact: Marzena Wątek, Dr Ludwik Rydygier Memorial Specialized Hospital Recruiting Kraków, Poland, 30-001 Contact: Małgorzata Raźny, Dr Regional Specialised Hospital in Legnica Recruiting Legnica, Poland, 59-220 Contact: Jadwiga Hołojda Independent Public University Hospital No. 1 in Lublin Recruiting Lublin, Poland, 20-001 Contact: Marek Hus, Prof. Clinical Hospital at the Karol Marcinkowski Medical University in Poznan Recruiting Poznań, Poland, 60-355 Contact: MAciej Kaźmierczak, Dr Copernicus Memorial Hospital in Lodz Comprehensive Cancer Center and Traumatology Recruiting Łódź, Poland, 93-513 Contact: Agnieszka Wierzbowska, Prof. +48426895191 agawierzbowska@wp.pl 收起 << |
NCT00562965 | Lymphoma, Follicular | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT02521493 | Blasts 5 Percent or More of Bo... 展开 >>ne Marrow Nucleated Cells Childhood Acute Myeloid Leukemia Childhood Myelodysplastic Syndrome Cytopenia Down Syndrome Myeloid Leukemia Associated With Down Syndrome Myeloproliferative Neoplasm Trisomy 21 Trisomy 21 Mosaicism 收起 << | Phase 3 | Recruiting | - | - |
NCT00562965 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT00414388 | - | Completed | - | - | |
NCT00414388 | Prostate Cancer | Phase 1 Phase 2 | Completed | - | United States, Illinois ... 展开 >> Onocology Specialists, S.C Niles, Illinois, United States, 60714 Oncology Specialists, S.C Park Ridge, Illinois, United States, 60068 收起 << |
NCT02879643 | ALL, Childhood ... 展开 >> Lymphoblastic Leukemia, Acute, Childhood Lymphoblastic Leukemia, Acute 收起 << | Phase 1 | Recruiting | May 1, 2021 | - |
NCT00744081 | AML | Phase 2 | Unknown | - | Germany ... 展开 >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany 收起 << |
NCT00372593 | Leukemia | Phase 3 | Completed | - | - |
NCT02303821 | Acute Lymphoblastic Leukemia (... 展开 >>ALL) 收起 << | Phase 1 | Recruiting | October 18, 2019 | - |
NCT02626338 | Relapsed/Refractory Acute Myel... 展开 >>oid Leukemia (AML) 收起 << | Phase 1 Phase 2 | Completed | - | United States, Arkansas ... 展开 >> University of Arkansas Little Rock, Arkansas, United States, 72205 United States, California City of Hope Medical Center Duarte, California, United States, 91010 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Houston Methodist Houston, Texas, United States, 77030 收起 << |
NCT00372593 | - | Completed | - | - | |
NCT00109837 | - | Completed | - | - | |
NCT00109837 | Leukemia | Phase 2 | Completed | - | - |
NCT03173612 | Acute Myeloid Leukemia | Not Applicable | Recruiting | December 2022 | China, Tianjin ... 展开 >> InstituteHBDH Recruiting Tianjin, Tianjin, China, 300020 Contact: Zhu Xiaofan 86-21-23909001 xfzhu@ihcams.ac.cn Principal Investigator: Guo Ye Principal Investigator: Yang Wenyu Principal Investigator: Chen Xiaojuan Principal Investigator: Chen Yumei Principal Investigator: Ruan Min 收起 << |
NCT00002835 | Lymphoma | Phase 3 | Completed | - | United States, Texas ... 展开 >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 收起 << |
NCT00079482 | Acute Myeloid Leukemia | Phase 2 | Completed | - | - |
NCT00180102 | Leukemia, Nonlymphocytic, Acut... 展开 >>e 收起 << | Phase 4 | Completed | - | Germany ... 展开 >> Medical Department I, University Hospital Carl Gustav Carus Dresden, Germany, 01307 收起 << |
NCT01004497 | Acute Lymphoblastic Leukemia | Phase 2 | Completed | - | Korea, Republic of ... 展开 >> Chonbuk National University Hospital Chonju, Chonbuk, Korea, Republic of, 561-712 Soonchunhyang University Bucheon Hospital Bucheon, Gyeonggi-do, Korea, Republic of, 420-767 National Cancer Center Goyang, Gyeonggi-do, Korea, Republic of, 410-769 Chonnam National University Hwasun Hospital Hwasun, Jeonnam, Korea, Republic of, 519-809 St. Vincent's Hospital, The Catholic University of Korea Suwon, Kyonggi-do, Korea, Republic of, 442-723 Yonsei University Severance Hospital Seoul, Korea, Republic of, 120-752 Catholic BMT Center, Seoul St. Mary's Hospital, The Catholic University of Korea Seoul, Korea, Republic of, 137-701 Korea University Guro Hospital Seoul, Korea, Republic of, 152-703 收起 << |
NCT00136084 | Leukemia, Myelocytic, Acute | Phase 3 | Completed | - | United States, California ... 展开 >> Stanford University Medical Center Palo Alto, California, United States, 94304 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Children's Hospital of Michigan (Wayne State University) Detroit, Michigan, United States, 48201 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 MD Anderson Cancer Center Houston, Texas, United States, 77030 Texas Children's Cancer Center Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 收起 << |
NCT03182244 | Acute Myeloid Leukemia With FM... 展开 >>S-like Tyrosine Kinase (FLT3) Mutation 收起 << | Phase 3 | Recruiting | June 2020 | - |
NCT00136084 | - | Completed | - | - | |
NCT01795872 | Multiple Sclerosis | Phase 4 | Completed | - | - |
NCT03072238 | Metastatic Prostate Cancer | Phase 3 | Recruiting | November 18, 2023 | - |
NCT02551718 | Acute Leukemia of Ambiguous Li... 展开 >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia 收起 << | Not Applicable | Recruiting | - | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker 206-616-1589 pbecker@u.washington.edu Principal Investigator: Pamela S. Becker 收起 << |
NCT02559765 | - | Completed | - | United Kingdom ... 展开 >> The University of Glasgow Glasgow, United Kingdom, G12 8LL 收起 << |
尊敬的 Ambeed 客户您好,
请您选择所在区域,我们将转接对应客服为您服务!